How do I interpret my genomic profiling results for Lung Cancer
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Your Lung Cancer Genomic Profiling Results
I'd be happy to help you understand genomic profiling for lung cancer! However, I notice you haven't shared your specific test results yet. Let me explain how to interpret these results, and then you can share your actual report so I can help explain what YOUR findings mean.
What Genomic Profiling Does
Genomic profiling analyzes the DNA mutations in your cancer cells to identify:
- Driver mutations - specific genetic changes that are fueling your cancer's growth
- Treatment targets - mutations that respond to specific targeted therapies
- Prognosis indicators - patterns that help predict how your cancer may behave
Key Mutations Oncologists Look For in Lung Cancer
According to NCCN Guidelines for Non-Small Cell Lung Cancer, doctors typically test for these important mutations:
| Mutation | What It Means | Treatment Implications | |----------|---------------|----------------------| | EGFR | Cancer cells have mutations in the EGFR gene | Often responds to EGFR inhibitor drugs (targeted therapy) | | ALK | A gene rearrangement that drives cancer growth | Responds to ALK inhibitor medications | | ROS1 | Another gene rearrangement | Responds to ROS1 inhibitor drugs | | BRAF V600E | A specific BRAF mutation | May respond to BRAF + MEK inhibitors | | KRAS | A common mutation in lung cancer | Newer targeted therapies now available (sotorasib, adagrasib) | | PD-L1 | Protein on cancer cells that hides from immune system | Predicts response to immunotherapy | | MSI/TMB | Tumor mutational burden (how many mutations) | High TMB may respond better to immunotherapy |
How to Read Your Report
When you look at your genomic profiling results, you'll typically see:
- Mutation Status - Listed as "Positive," "Negative," or "Not Detected"
- Percentage/Allele Frequency - How many cancer cells carry this mutation
- Clinical Significance - Whether it's actionable (has treatment options)
Next Steps
Please share your genomic profiling report, and I can help you:
- ✅ Explain what each finding means
- ✅ Interpret the specific mutations detected
- ✅ Summarize the clinical significance
- ✅ Help you formulate questions for your oncologist
Questions to Ask Your Oncologist
While you're gathering your results, here are key questions to ask:
- "What mutations were found in my tumor, and what do they mean?"
- "Are any of these mutations 'actionable' - meaning there are targeted drugs available?"
- "Based on my genomic results, what treatment options do you recommend?"
- "What is my PD-L1 status, and how does that affect immunotherapy options?"
- "Were there any unexpected findings I should know about?"
Once you upload your genomic profiling report, I can provide specific interpretation of YOUR results. This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Non-Small Cell Lung Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with diagnosis for Lung Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: